The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Background There is paucity of data describing the impact of COVID-19 pandemic on
antimicrobial resistance. This review evaluated the changes in the rate of multidrug resistant …

Prior to coronavirus disease 2019 (COVID-19), tuberculosis (TB) was the worst killer among
infectious diseases. The union of these two obnoxious respiratory diseases can be …

While it is reported that COVID-19 patients are more prone to secondary bacterial infections,
which are strongly linked to the severity of complications of the disease, bacterial …

Τhe COVID-19 pandemic highly impacted the circulation, seasonality, and morbidity burden
of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory …

Introduction In the Northeast US, respiratory viruses such as influenza and respiratory
syncytial virus (RSV), which were largely suppressed by COVID-19-related social …

Bacterial co-infections may aggravate COVID-19 disease, and therefore being cognizant of
other pathogens is imperative. We studied the types, frequency, antibiogram, case fatality …

There was important heterogeneity in the retrieved literature on the epidemiology of MRSA
lung infection in patients with COVID-19, both when considering all other bacteria as the …

Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many
measures of increased inflammation in severe COVID-19 that also accompany its …

COVID-19 is characterized by hyperactivation by inflammatory cytokines and recruitment of
macrophages, neutrophils, and other immune cells, all hallmarks of a strong inflammatory …